Clinical Outcomes of Treatment for Tongue Cancer at Tokushima University Hospital
Practica oto-rhino-laryngologica. Suppl.(2022)
Abstract
In the present retrospective study, a total of 42 patients with tongue cancer who had received their primary treatment at the Department of Otolaryngology Head and Neck Surgery, Tokushima University Hospital, between January 2010 and December 2015 were enrolled. The patients consisted of 24 men and 18 women, with a mean age of 63.7 years (range 30–93 years). The 5-year overall and disease-specific survival rates were 65.7% and 67.7%, respectively. The 5-year overall survival rates according to the disease stage were as follows: stage I, 85.7%; stage II, 85.7%; stage III, 66.6%; stage IVA, 36.1%. The 5-year overall survival rates according to the T stage were as follows: T1, 85.7%; T2, 63.1%; T3, 62.5%; T4, 50.0%. The 5-year overall survival rates according to the N stage were as follows: N0, 86.9%; N1, 50.0%; N2b, 34.0%; N2c, 0%.
MoreTranslated text
Key words
tongue cancer,clinical outcomes,treatment
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined